List of Calcium Gluconate In Sodium Chloride drug patents

Calcium Gluconate In Sodium Chloride is owned by Hq Spclt Pharma.

Calcium Gluconate In Sodium Chloride contains Calcium Gluconate.

Calcium Gluconate In Sodium Chloride has a total of 2 drug patents out of which 0 drug patents have expired.

Calcium Gluconate In Sodium Chloride was authorised for market use on 29 October, 2018.

Calcium Gluconate In Sodium Chloride is available in solution;intravenous dosage forms.

The generics of Calcium Gluconate In Sodium Chloride are possible to be released after 25 July, 2037.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10342813 HQ SPCLT PHARMA Calcium gluconate solutions in flexible containers
Jul, 2037

(14 years from now)

US10130646 HQ SPCLT PHARMA Calcium gluconate solutions in flexible containers
Jul, 2037

(14 years from now)

Drugs and Companies using CALCIUM GLUCONATE ingredient

Market Authorisation Date: 29 October, 2018

Treatment: NA

Dosage: SOLUTION;INTRAVENOUS

More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in